DCF — TRIOS HEALTH
Enterprise Value: $-252.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-252.6M
Enterprise Value
$-79.9M
PV of Cash Flows
$-172.6M
PV of Terminal Value
$-278.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $159.3M | $-15.7M | -10.0% | $-22.5M | $-20.4M |
| Year 2 | $164.1M | $-14.5M | -9.0% | $-21.5M | $-17.8M |
| Year 3 | $169.0M | $-13.3M | -8.0% | $-20.4M | $-15.4M |
| Year 4 | $174.0M | $-12.8M | -7.0% | $-20.2M | $-13.8M |
| Year 5 | $179.3M | $-12.8M | -7.0% | $-20.3M | $-12.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-252.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$154.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.10364586628977192
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5